Anafranil
In brief
- Anafranil (clomipramine) is supplied by retail and hospital pharmacies and by online suppliers; it is officially a prescription-only medicine in Canada, the US and most countries, though availability varies and some pharmacies or online vendors may supply it without a prescription.
- Anafranil is used mainly to treat obsessive–compulsive disorder (OCD) and sometimes depressive disorders; it is a tricyclic antidepressant that primarily inhibits the reuptake of serotonin and norepinephrine (strong serotonergic activity) and has anticholinergic effects.
- Typical adult dosing for OCD starts at about 25 mg/day (often at bedtime) with gradual increases; maintenance dosing is commonly 100–250 mg/day (maximum 250 mg/day); for depression doses are individualised and often up to ~150 mg/day; paediatric dosing for OCD often starts at 25 mg/day and may be titrated to ~3 mg/kg/day (with maximums per local guidance).
- Administration is oral, in tablet or capsule form (commonly available in 10 mg, 25 mg, 50 mg and 75 mg strengths depending on country and brand).
- Initial symptom improvement may be seen in 2–4 weeks for some patients, but significant clinical benefit for OCD frequently takes 6–12 weeks of treatment.
- The clinical effects from a single dose typically last around 24 hours (dosing may be once daily or divided); therapeutic benefits require continuous treatment over weeks to months for maintenance.
- Avoid or limit alcohol while taking Anafranil — alcohol can increase sedation, worsen side effects (drowsiness, dizziness) and exacerbate risks such as impaired coordination and CNS depression.
- The most common side effects include drowsiness/sedation and anticholinergic effects such as dry mouth and constipation; other frequent effects are dizziness, tremor, tachycardia, orthostatic hypotension, weight gain and blurred vision.
- Would you like to try anafranil without a prescription?
Critical Warnings And Restrictions In Canada
Basic Anafranil Information
- INN (International Nonproprietary Name): Clomipramine.
- Brand Names Available In Canada (English): Anafranil — capsules commonly supplied in 25 mg, 50 mg and 75 mg packaging.
- ATC Code: N06AA04.
- Forms & Dosages: Capsules and tablets; dosages reported internationally include 10 mg (varies), 25 mg, 50 mg and 75 mg for oral use.
- Manufacturers In Canada (English): not specified.
- Registration Status In Canada (English): not specified.
- OTC / Rx Classification: Prescription-only medication (Rx) in countries surveyed; prescription-only status applies in Canada.
Safety-first summary for patients and caregivers: Anafranil (clomipramine) is a prescription-only tricyclic antidepressant with significant anticholinergic and cardiac risk.
Patients must tell prescribers about heart disease, recent myocardial infarction, seizure history, severe liver disease, glaucoma, urinary retention or prostatic hypertrophy, and any recent use of MAO inhibitors before a prescription is issued.
Watch for orthostatic hypotension, tachycardia, and signs of serotonin syndrome when Anafranil is combined with other serotonergic medicines.
Start elderly patients at the lowest possible dose and titrate slowly.
Pregnant or breastfeeding patients should discuss risks and benefits with their prescriber and avoid abrupt discontinuation.
When working with Indigenous patients, use culturally safe communication and coordinate with community health resources for follow-up and supports.
Absolute Contraindications
- Recent myocardial infarction.
- History of hypersensitivity to clomipramine or other tricyclics.
- Concurrent use of MAO inhibitors or within recommended washout periods.
- Acute recovery phase after a heart attack.
- Severe liver disease.
Relative Contraindications / Conditions Needing Monitoring
- Known cardiac disease, conduction disorders or arrhythmias.
- History of seizures.
- Urinary retention or prostatic hypertrophy.
- Closed-angle glaucoma.
- Hyperthyroidism or unstable thyroid disease.
Pre-Prescription Screening Checklist
- Current or recent MAOI use — confirm washout period before starting Anafranil.
- Cardiac history — ask about heart disease, previous arrhythmias and recent myocardial infarction.
- Seizure history and current anticonvulsant therapy.
- Current medications including OTC antihistamines, anticholinergics, SSRIs/SNRIs and QT‑prolonging drugs.
- Pregnancy status and breastfeeding plans.
- History of glaucoma or urinary retention.
Monitoring Schedule
| Assessment | When To Do It | Notes |
|---|---|---|
| ECG | Baseline; repeat if dose increases substantially or if cardiac history exists | Recommended if age >65 or known conduction disease |
| Electrolytes (K+, Mg2+) | Baseline in patients at cardiac risk; as clinically indicated thereafter | Low potassium/magnesium increases arrhythmia risk |
| Liver Function Tests | Baseline if severe liver disease suspected; monitor clinically | No formal dose adjustment defined; use caution |
| Orthostatic Vital Signs | Baseline and after dose changes (first week) | Look for orthostatic hypotension to reduce fall risk |
| Medication Review | Baseline, weekly during titration, then monthly | Identify interactions, anticholinergic burden and sedation risks |
High-Risk Groups
Elderly patients are more sensitive to anticholinergic effects, orthostatic hypotension and falls, so geriatric dose reductions and a pharmacist-led medication review are recommended.
Pregnancy has limited data for Anafranil; prescribers should weigh maternal benefit against fetal risk and consult obstetrics when possible.
Small amounts of clomipramine are excreted in breastmilk; monitor infants for sedation or feeding problems if the parent is breastfeeding.
For Indigenous health care, ensure culturally competent mental-health services, local pharmacy access and planning for travel or remote supply challenges.
Monitoring Checklist For High-Risk Groups
- Baseline ECG and review of cardiac medications.
- Fall-risk assessment and orthostatic vitals.
- Full medication reconciliation for anticholinergic burden.
Interaction With Activities
Anafranil can cause drowsiness, dizziness and blurred vision, which slow reaction times.
Counsel patients to avoid driving or operating heavy machinery until they know how Anafranil affects them.
Under workplace safety guidance, employees in safety-sensitive roles may need to disclose medication use to their employer per provincial rules.
Q&A — Can I Drive After Taking It In Canada?
Short answer: No until you know how it affects you.
If you feel drowsy, dizzy or have blurred vision, do not drive or operate machinery.
Document counselling in pharmacy or clinical notes and check provincial rules for safety-sensitive job reporting.
Usage Basics For Canadians
INN, Brand Names Available In Canada
Clomipramine is the International Nonproprietary Name (INN) for the medicine commonly sold as Anafranil in Canada.
Anafranil capsules are commonly available in 25 mg, 50 mg and 75 mg strengths in Canadian practice.
The ATC code for clomipramine is N06AA04, placing it in tricyclic antidepressants.
Definitions
- INN: Clomipramine.
- Brand: Anafranil (commonly used in Canada).
- ATC: N06AA04 — tricyclic antidepressant class.
Legal Classification Under Health Canada
Anafranil is prescription-only across jurisdictions in Canada.
Pharmacists verify a valid prescription, patient identity, dosing and potential interactions at dispensing.
Look for a Drug Identification Number (DIN) on the Canadian label to confirm an authorised product.
Steps To Obtain And Verify A Prescription
- Obtain a valid prescription from a licensed practitioner.
- Present photo ID at the pharmacy if required by provincial regulations.
- Ask the pharmacist to confirm the DIN and check packaging for strength and expiry.
- Report adverse events through Health Canada’s MedEffect system and to the dispensing pharmacy.
Canadian Dosing Guide
Standard Regimens (Health Canada Approved)
For obsessive-compulsive disorder (OCD), adults typically start with 25 mg at bedtime and increase by approximately 25 mg every few days as tolerated.
Maintenance doses commonly range from 100 mg to 250 mg per day divided into two or three doses, with a maximum of 250 mg/day.
Pediatric OCD dosing (where approved) often starts at 25 mg and may increase toward 3 mg/kg/day with a maximum around 200 mg/day for adolescents, depending on product labelling.
For off-label depression, doses are individualised and often up to 150 mg/day.
| Age Group | Starter Dose | Maintenance Dose | Maximum Dose |
|---|---|---|---|
| Adults | 25 mg at bedtime, increase by ~25 mg every few days | 100–250 mg/day divided | 250 mg/day |
| Adolescents (OCD, where labelled) | Start 25 mg/day | Titrate toward 3 mg/kg/day as tolerated | Approx. 200 mg/day (product-dependent) |
| Children | Per product monograph and specialist guidance | Individualised | Refer to product monograph |
Titration Steps
- Begin with 25 mg nightly and assess tolerance for 2–3 days.
- Increase by 25 mg every few days if tolerated, splitting doses as needed for daytime tolerability.
- Monitor side effects closely during the first 2–3 weeks of titration.
Adjustments For Comorbidities
There are no formal standardised dose adjustments for renal or hepatic impairment; exercise caution and monitor clinically.
Patients with diabetes should be monitored for weight changes and autonomic symptoms such as tachycardia, which can mask hypoglycaemia.
For patients with cardiac disease, obtain a baseline ECG and electrolytes and consider cardiology input if conduction defects or high arrhythmia risk exist.
Q&A — What If I Miss A Dose Under My Provincial Drug Plan?
If a dose is missed, take it as soon as remembered unless the next dose is near; do not double up doses.
Administrative coverage or refill issues under provincial plans (Ontario Drug Benefit, BC PharmaCare, RAMQ) require contacting the pharmacy or insurer for emergency supply policies.
Ask your prescriber or pharmacist about auto-refill or synchronized dispensing to avoid gaps.
Interaction Chart (Canadian Context)
Food And Drinks
Alcohol increases sedation and orthostatic risks when combined with Anafranil.
Caffeine can worsen anxiety or tremor for some patients on clomipramine; advise moderation during titration.
Grapefruit is not a major known interaction with clomipramine, but check the product monograph for formulation-specific notes.
| Food/Drink | Interaction | Patient Advice |
|---|---|---|
| Alcohol | Added sedation, increased orthostatic hypotension | Avoid or minimise, especially during titration |
| Caffeine | May worsen anxiety or tremor | Limit intake if anxious or shaky |
| Grapefruit | No major interaction noted broadly | Check product monograph for specific formulations |
Practical Advice
- Do not drink alcohol while starting or increasing Anafranil.
- Reduce caffeine if experiencing increased anxiety or tremor.
- Ask the pharmacist about food-related guidance on the specific brand dispensed.
Common Drug Conflicts
Major interaction risks include concurrent MAO inhibitors and other strongly serotonergic drugs, which raise serotonin syndrome risk.
Additive anticholinergic effects occur with first-generation antihistamines, some antipsychotics and urinary antispasmodics.
Co-prescribing QT-prolonging medicines increases cardiac arrhythmia risk and should prompt review.
Stop / Review / Monitor Checklist
- Stop or avoid combining with MAO inhibitors; ensure appropriate washout.
- Review any serotonergic drugs (SSRIs, SNRIs, triptans) and plan tapering or monitoring to reduce serotonin syndrome risk.
- Monitor for anticholinergic burden when other antimuscarinics are present.
| High-Risk Drug Class | Typical Risk | Recommended Action |
|---|---|---|
| MAO Inhibitors | Serotonin syndrome, severe interactions | Avoid; observe recommended washout periods |
| SSRIs / SNRIs / Triptans | Increased serotonin effects | Review; monitor closely for serotonin syndrome |
| Anticholinergics (antihistamines, antispasmodics) | Dry mouth, constipation, urinary retention | Reduce combination use where possible; monitor |
| QT-Prolonging Agents | Prolonged QT, arrhythmia | Check ECG and electrolytes; avoid combinations if possible |
User Reports And Trends In Canada
Canadian Patient Forums And Review Platforms
Patients frequently report early sedation, dry mouth and constipation after starting Anafranil, with symptom improvement for obsessive-compulsive symptoms after weeks of adherence.
Online discussion often places clomipramine as a next step when multiple SSRI trials have failed for OCD.
Emphasise verified sources and advise against following anecdotal dosage advice found on forums.
- Common reported benefits: reduction in compulsive behaviours and intrusive thoughts when tolerated long-term.
- Common reported side effects: sedation, dry mouth and constipation.
- Typical patient concern: switching from SSRIs and managing side effects during titration.
Community Pharmacy Feedback
Pharmacists note adherence challenges during titration and frequent requests for blister packaging or dose-splitting aids to manage incremental increases.
Older adults commonly experience anticholinergic side effects, prompting medication reviews and deprescribing discussions.
Chain and independent community pharmacies liaise with prescribers for dose adjustments, substitution and provincial coverage queries.
Access & Purchase Options
National Pharmacy Chains And In-Store Realities
Anafranil and generic clomipramine are dispensed through major Canadian chains and independent pharmacies, although local stock may vary.
Check the DIN, packaging and bilingual labelling when picking up a prescription in Quebec or bilingual regions.
Community pharmacists can arrange special orders when a particular strength is not in stock.
- At pickup, check DIN, expiry date and dosing instructions.
- Ask about generic equivalents and cost-saving options.
- Request counselling on side effects, driving safety and medication interactions.
In our online pharmacy, anafranil is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Online Pharmacies In Canada & Provincial Restrictions
Licensed Canadian online pharmacies require a valid prescription and should be approved by the relevant provincial college or regulatory body.
Some provinces restrict out-of-country supply; using Canadian-licensed suppliers ensures post-market surveillance and easier adverse-event reporting.
Checklist To Verify An Online Pharmacy
- Ask for the pharmacy licence number and confirm with the provincial college.
- Verify that a valid prescription is required and that a pharmacist is available for counselling.
- Look for Verified Internet Pharmacy Practice Sites or provincial equivalents where applicable.
Mechanism And Pharmacology
Simplified Explanation (Patient-Friendly)
Clomipramine is a tricyclic antidepressant that strongly inhibits serotonin reuptake and also affects norepinephrine reuptake to a lesser degree.
Its strong serotonergic action is the reason for effectiveness in obsessive-compulsive disorder, while anticholinergic activity explains common side effects like dry mouth and constipation.
Clinical benefit for OCD usually takes several weeks to develop.
Quick Definitions
- Mechanism: Serotonin reuptake inhibition (strong) plus some norepinephrine reuptake inhibition.
- Onset Of Action: Weeks for anti‑obsessional benefit.
- Side-Effect Drivers: Anticholinergic and cardiac effects.
Clinical Terms And Monograph References
Clinicians should consult the official product monograph for pharmacokinetics, half-life, metabolites and CYP enzyme interactions.
Therapeutic monitoring is important in the polypharmacy common in older adults due to metabolic and interaction risks.
Indications & Off-Label Uses In Canada
Approved Indications (DIN)
The primary approved indication is obsessive-compulsive disorder (OCD).
Health authorities and product labelling support use in adults and certain paediatric patients for OCD where indicated.
| Indication | Typical Starting Dose | Typical Maintenance Dose |
|---|---|---|
| Obsessive-Compulsive Disorder (OCD) | 25 mg at bedtime, titrate by ~25 mg every few days | 100–250 mg/day divided |
| Depression (Off-Label) | Individualised | Often up to 150 mg/day |
Common Off-Label Practices
Off-label uses may include treatment-resistant depression, panic disorder or adjunctive therapy in specialist care.
Off-label prescribing should be documented with a clear rationale and a monitoring plan and discussed in shared decision-making with the patient.
Key Clinical Findings
Canadian And International Studies 2022–2025
Recent literature supports clomipramine’s efficacy for refractory OCD when SSRIs are ineffective, but also shows higher anticholinergic and cardiac adverse event rates compared with SSRIs.
Canadian cohort reports emphasise careful use in older adults and patients with cardiac comorbidities.
- Study Themes: Efficacy in SSRI-refractory OCD.
- Study Themes: Comparative tolerability vs SSRIs — increased anticholinergic burden.
- Study Themes: Safety concerns in older populations and cardiac risk management.
Ongoing Health Canada Safety Monitoring
Post-marketing surveillance captures adverse events and serious reactions should be reported via Health Canada’s MedEffect system.
Pharmacovigilance focuses on overdose toxicity, anticholinergic sequelae and cardiac conduction abnormalities.
Alternatives Matrix
Comparable Medicines With DIN In Canada
SSRIs such as sertraline, fluoxetine and paroxetine are typically first-line agents for OCD because of better tolerability.
Clomipramine is generally reserved for SSRI-refractory cases or when a specialist recommends it.
| Drug/Class | Efficacy For OCD | Side-Effect Profile | Monitoring Needs |
|---|---|---|---|
| Clomipramine (Anafranil) — TCA | High anti‑obsessional efficacy | Anticholinergic effects, sedation, cardiac risk | ECG if cardiac risk; medication review for interactions |
| Sertraline — SSRI | Effective for OCD; first line | GI upset, insomnia or somnolence, sexual side effects | Routine follow-up; monitor for serotonin effects |
| Fluoxetine — SSRI | Effective for OCD; long half-life | Insomnia, activation, sexual side effects | Monitor interactions due to long half-life |
| Imipramine — TCA | Antidepressant; sometimes used off-label | Anticholinergic, cardiac effects | ECG if indicated; similar monitoring to clomipramine |
Pros And Cons Checklist
- Pros: Potent anti‑obsessional efficacy and an established track record for refractory OCD.
- Cons: Higher anticholinergic and cardiac risk, sedating effects and many drug interactions.
- Shared Decision Points: Discuss efficacy versus side-effect burden and the monitoring commitments required.
Common Questions From Canadian Patients
Is Anafranil Safe In Pregnancy Or Breastfeeding?
Discuss risk versus benefit with an obstetrician or specialist; small amounts may pass into breastmilk and infants should be monitored for sedation.
How Do I Switch From An SSRI To Anafranil?
Switching requires careful planning to avoid serotonin syndrome; follow washout or cross-taper rules and consult prescriber or pharmacist.
When Will I See Benefits For OCD?
Anti‑obsessional effects usually appear over several weeks with sustained treatment.
Are There Withdrawal Risks?
Taper gradually to avoid withdrawal symptoms; abrupt discontinuation is not advised.
What About Refills And Travel?
Carry the original prescription and packaging when travelling and contact your provincial pharmacy for emergency refill policies.
- For serious adverse events, report to Health Canada MedEffect and notify the dispensing pharmacy.
- For coverage questions, contact your provincial drug plan or private insurer.
Coverage & Purchase Comparison Table
| Province / Plan | Coverage Status | Prior Authorization | Typical Patient Cost | Notes |
|---|---|---|---|---|
| Ontario Drug Benefit (ODP) | Varies (may require case-by-case review) | Possible, depending on indication and age | Varies by plan and generic availability | Verify with pharmacist and provincial formulary |
| BC PharmaCare | Varies | Possible prior authorization | Patient copay varies | Check PharmaCare Special Authority rules |
| RAMQ (Quebec) | Varies | May require documentation | Depends on public/private coverage | Bilingual labelling often provided |
| Private Insurers | Partial or full, plan-dependent | Possible | Varies by deductible and formulary | Submit receipts and DIN for reimbursement |
Step-By-Step Purchase Checklist For Canadian Patients
- Valid prescription from a licensed prescriber.
- Request the DIN on the dispensed label.
- Ask the pharmacist about generic options and cost differences.
- Verify provincial coverage and any prior authorization requirements.
- Consider blister packs or weekly packaging for adherence during titration.
- Obtain pharmacist counselling on side effects, driving safety and interactions.
Registration & Regulation
Health Canada Approval
Anafranil/clomipramine is prescription-only and is recognised internationally as a treatment option for OCD.
Confirm marketing authorisation and the DIN on packaging or via the Health Canada Drug Product Database for specific product details.
Report adverse events to Health Canada and the dispensing pharmacy.
Regulatory Terms
- DIN: Drug Identification Number — unique identifier for marketed drug products in Canada.
- Product Monograph: Official label and clinical information that accompanies the product.
- MedEffect: Health Canada’s adverse-event reporting system.
DIN Number And Labelling Requirements
Canadian packaging must display a Drug Identification Number (DIN), expiry date, manufacturer and storage instructions.
Bilingual labelling is required in some regions and pharmacists should document counselling when dispensing high-risk psychotropics like Anafranil.
Storage & Handling
Standard Canadian Household Conditions
Store Anafranil at 20–25°C (68–77°F), protected from light and moisture and in the original packaging.
Keep all medications out of reach of children and pets and secure them in households with cognitive impairment or substance-use risks.
- Store in a dry, cool place away from direct sunlight.
- Keep in original container with child-resistant cap where provided.
- Dispose of expired or unwanted medicine via pharmacy take-back programs.
Cold-Chain Requirements
No cold-chain requirements exist for standard oral capsules.
For remote or northern communities, plan for reliable supply and protect shipments from extreme temperatures during transport.
Discuss local emergency refill options with the community pharmacy if travel or weather may delay delivery.
Guidelines For Proper Use
Canadian Pharmacist Guidance
Pharmacists should confirm the diagnosis and review the full medication list for interactions such as MAOIs, serotonergic drugs and QT-prolonging agents.
Document counselling about sedation, orthostasis and anticholinergic effects and schedule follow-up checks.
Recommend ECG if the patient has cardiac history or is older than 65.
Counselling Points And Monitoring Timeline
- Baseline: medication review, ECG if indicated, electrolytes if cardiac risk.
- 1–2 Weeks: check for early side effects, orthostatic symptoms and adherence.
- Monthly: monitor efficacy, side effects and medication interactions.
- ECG: perform at baseline and repeat if dose increases substantially or symptoms suggest conduction change.
Provincial Health Authority Recommendations
Follow provincial mental-health pathways that typically recommend SSRIs as first-line therapy for OCD and escalation to clomipramine for refractory cases.
Refer to psychiatry when doses approach high maintenance ranges (greater than about 150 mg/day) or when adverse effects emerge.
Document informed consent and a plan for gradual tapering when discontinuation is planned.
Treatment Pathway (Suggested)
- SSRI Trial → Reassess Response → Consider Anafranil For SSRI-Refractory OCD ± Psychotherapy → Specialist Referral If High Dose Or Poor Tolerance.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Halifax | Nova Scotia | 5-9 days |
| Québec City | Quebec | 5-9 days |
| St. John’s | Newfoundland and Labrador | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Victoria | British Columbia | 5-7 days |
| Charlottetown | Prince Edward Island | 5-9 days |
Final Notes
Anafranil (clomipramine) remains an important option for treatment-resistant OCD when SSRIs are ineffective, but it requires careful prescriber and pharmacist oversight due to anticholinergic and cardiac risks.
Confirm the DIN on any dispensed product, review all current medications for interactions and encourage patients to report side effects promptly.
For any serious or unexpected reactions, report to Health Canada’s MedEffect and notify the dispensing pharmacy so pharmacovigilance can be maintained.